Beese Fulmer Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $381K | Buy |
939
+467
| +99% | +$189K | 0.03% | 209 |
|
|
2025
Q1 | $235K | Buy |
472
+6
| +1% | +$2.99K | 0.02% | 219 |
|
|
2024
Q4 | $242K | Hold |
466
| – | – | 0.02% | 203 |
|
|
2024
Q3 | $288K | Buy |
466
+1
| +0.2% | +$619 | 0.02% | 193 |
|
|
2024
Q2 | $257K | Hold |
465
| – | – | 0.02% | 198 |
|
|
2024
Q1 | $270K | Hold |
465
| – | – | 0.03% | 193 |
|
|
2023
Q4 | $247K | Hold |
465
| – | – | 0.03% | 198 |
|
|
2023
Q3 | $235K | Hold |
465
| – | – | 0.03% | 191 |
|
|
2023
Q2 | $243K | Hold |
465
| – | – | 0.03% | 192 |
|
|
2023
Q1 | $268K | Sell |
465
-21
| -4% | -$12.1K | 0.03% | 189 |
|
|
2022
Q4 | $268K | Buy |
486
+21
| +5% | +$11.6K | 0.03% | 186 |
|
|
2022
Q3 | $236K | Hold |
465
| – | – | 0.03% | 185 |
|
|
2022
Q2 | $253K | Hold |
465
| – | – | 0.03% | 192 |
|
|
2022
Q1 | $275K | Sell |
465
-250
| -35% | -$148K | 0.03% | 191 |
|
|
2021
Q4 | $477K | Hold |
715
| – | – | 0.05% | 161 |
|
|
2021
Q3 | $409K | Buy |
715
+120
| +20% | +$68.6K | 0.05% | 166 |
|
|
2021
Q2 | $300K | Buy |
595
+10
| +2% | +$5.04K | 0.03% | 180 |
|
|
2021
Q1 | $267K | Buy |
+585
| New | +$267K | 0.03% | 184 |
|
|
2020
Q3 | – | Sell |
-335
| Closed | -$121K | – | 514 |
|
|
2020
Q2 | $121K | Buy |
+335
| New | +$121K | 0.02% | 227 |
|